Georgetown Lombardi Clinical Trial Helps Advance Use of Immunotherapy in Liver Cancer
January 6th, 2020
In August of 2016, Dan Hilton arrived at MedStar Georgetown University Hospital to be evaluated for a liver transplant. He had been diagnosed with cirrhosis, the result of a hepatitis C infection contracted many years earlier. After multiple tests, he received unexpected news; the doctors found tumors on his liver.
Understanding the Microbiome and its Effect on Treatment of Patients with Colorectal Cancer
January 6th, 2020
In an interview with Targeted Oncology at the 2019 Ruesch Center Symposium, Weinberg shared key points from his discussion on mining the microbiome in patients with CRC and summarized the treatment landscape for patients with metastatic disease. He also discussed an upcoming basket trial that uses liquid biopsies to place patients on treatment plans that will be most effective for their individual needs.
Scientific Presentations at 2019 Ruesch Symposium Inspire
December 10th, 2019
The 10th Annual Ruesch Symposium provided a forum for discussions on cutting-edge research and the pipeline of promising new therapies and technologies in GI cancers.
Does the tumor microbiome play a role in early-onset colorectal cancer?
October 30th, 2019
The human body is composed of around a trillion cells, and there are a trillion to a trillion-and-a-half bacterial cells composing our gut microbiome. Of these bacteria, some are good and help us digest foods. Others can behave badly and are associated with diseases such as autoimmunity and cancer.
The Quest for a Cure: Cancer Expert John Marshall ’79 on Battling the Disease in His Work and His Family
October 25th, 2019
Dr. John Marshall was recently the keynote “Faces of Cancer” event at his alma mater, the Episcopal High School in Alexandria VA. He shared his personal experiences with cancer and discussed myths about the disease, the economics of treatment, and his work to advance genetics-driven precision medicine.
